BST2 and breast cancer: Recent studies have demonstrated that the mRNA and protein expression of BST-2 are elevated in various cancers including: head and neck cancer, oral cavity cancer, glioblastoma, lung cancer, endometrial cancer, lymphomas, and breast cancers [20–26].